|
Video: What is a Stock Split?
|
|
Raptor Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing therapeutics that treat debilitating and often fatal diseases. Co.'s product includes: PROCYSBI® (cysteamine bitartrate) delayed-release capsules, for the management of nephropathic cystinosis in adults and children six years and older. Co.'s other clinical-stage product candidates include RP103, which contains, cysteamine bitartrate, and utilizes Co.'s proprietary capsule formulation containing delayed-release enteric coated microbeads of cysteamine bitartrate. Co.'s preclinical candidates include include RP105 and RP 106 being developed for a range of rare diseases. According to our RPTP split history records, RPTP has had 1 split. | |
|
RPTP (RPTP) has 1 split in our RPTP split history database. The split for RPTP took place on September 30, 2009. This was a 1 for 17 reverse split, meaning for each 17 shares of RPTP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 58.8235294117647 share position following the split.
When a company such as RPTP conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the RPTP split history from start to finish, an original position size of 1000 shares would have turned into 58.8235294117647 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into RPTP shares, starting with a $10,000 purchase of RPTP, presented on a split-history-adjusted basis factoring in the complete RPTP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/09/2014 |
|
End date: |
10/25/2016 |
|
Start price/share: |
$8.51 |
|
End price/share: |
$9.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
5.76% |
|
Average Annual Total Return: |
3.03% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,576.19 |
|
Years: |
1.88 |
|
|
|
Date |
Ratio |
09/30/2009 | 1 for 17 |
|
|